# AIDs
The optimal timing for initiating antiretroviral therapy (ART) remains uncertain, particularly in resource-limited settings. We analyzed data from a long-term, population-based cohort in China using a Bayesian multi-state model to assess the impact of ART initiation timing on survival outcomes and cost-effectiveness.
